相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Pituitary Society update to acromegaly management guidelines
Maria Fleseriu et al.
PITUITARY (2021)
Improvement in Symptoms and Health-Related Quality of Life in Acromegaly Patients: A Systematic Review and Meta-Analysis
Leonie H. A. Broersen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Cost-Utility of Acromegaly Pharmacological Treatments in a French Context
Thierry Brue et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands
Maria Fleseriu et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Andrea Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies
Maria Fleseriu et al.
PITUITARY (2020)
Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice
Eliza B. Geer et al.
BMC ENDOCRINE DISORDERS (2020)
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Monica R. Gadelha et al.
ENDOCRINE REVIEWS (2019)
Pegvisomant Improves Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
Tiziana Feola et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Patients' perspectives on acromegaly diagnostic delay: a qualitative study
Jordan Sibeoni et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ
Maria Fleseriu et al.
PITUITARY (2019)
The Clinicopathological Spectrum of Acromegaly
Amit Akirov et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy
Thierry Brue et al.
ENDOCRINE (2019)
Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly
Xavier Badia et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
A Consensus Statement on acromegaly therapeutic outcomes
Shlomo Melmed et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY
Michael Buchfelder et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Update on quality of life in patients with acromegaly
Iris Crespo et al.
PITUITARY (2017)
Acromegaly: clinical features at diagnosis
Lucio Vilar et al.
PITUITARY (2017)
Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry
Luigi Maione et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly
Aart J. van der Lely et al.
PITUITARY (2017)
Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study
Nikolaos Kyriakakis et al.
CLINICAL ENDOCRINOLOGY (2017)
Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly
Christian J. Strasburger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Quality of Life in Acromegaly
Susan M. Webb et al.
NEUROENDOCRINOLOGY (2016)
Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study
Philippe J. Caron et al.
PITUITARY (2016)
Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters
Victor J. Geraedts et al.
FRONTIERS IN ENDOCRINOLOGY (2016)
Six weeks of conditioning exercise increases total, but not free testosterone in lifelong sedentary aging men
Lawrence D. Hayes et al.
AGING MALE (2015)
More concerns and stronger beliefs about the necessity of medication in patients with acromegaly are associated with negative illness perceptions and impairment in quality of life
Cornelie D. Andela et al.
GROWTH HORMONE & IGF RESEARCH (2015)
The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL
Kenichi Yoshida et al.
PITUITARY (2015)
Affected Illness Perceptions and the Association with Impaired Quality of Life in Patients with Long-Term Remission of Acromegaly
Jitske Tiemensma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
PITUITARY TUMORS Coping with 'cured' pituitary tumors
Susan M. Webb
NATURE REVIEWS ENDOCRINOLOGY (2011)
Clinical, quality of life, and economic value of acromegaly disease control
A. Ben-Shlomo et al.
PITUITARY (2011)
Short- and long-term changes of quality of life in patients with acromegaly: Results from a prospective study
C. Sardella et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2010)
Acromegaly pathogenesis and treatment
Shlomo Melmed
JOURNAL OF CLINICAL INVESTIGATION (2009)
Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant
S. J. C. M. M. Neggers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study
I. Schreiber et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Medical progress: Acromegaly
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study
Susan M. Webb et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess
NR Biermasz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly:: development and psychometric properties
SM Webb et al.
CLINICAL ENDOCRINOLOGY (2002)
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
AJ van der Lely et al.
LANCET (2001)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
PJ Trainer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
